A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies

E. J. Bow*, C. Rotstein, G. A. Noskin, M. Laverdière, A. P. Schwarer, B. H. Segal, J. F. Seymour, J. Szer, S. Sanche

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

83 Scopus citations

Fingerprint Dive into the research topics of 'A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences